Moolec Science Ltd. is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. Moolec Science Ltd., formerly known as LightJump Acquisition Corporation, is based in WARWICK, United Kingdom.
| Revenue (Most Recent Fiscal Year) | $5.62M |
| Net Income (Most Recent Fiscal Year) | $-7.31M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4.10 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 10.99 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -105.71% |
| Return on Equity (Trailing 12 Months) | -162.27% |
| Return on Assets (Trailing 12 Months) | -25.16% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.48 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.73 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 6.99 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.77 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.20 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 4.01M |
| Free Float | 3.21M |
| Market Capitalization | $32.10M |
| Average Volume (Last 20 Days) | 3518.45 |
| Beta (Past 60 Months) | -0.39 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 19.90% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.07% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |